Get the app
HealthcareMachine Learning4 min reading time

AI drug development startup Pathos AI closes $237M investment

SiliconANGLE
Read the full article
Pathos AI raised $237M at a $3B valuation to advance its AI-driven cancer drug development platform, Foundry, which analyzes vast oncological data to identify promising drug candidates and plan biomarker-driven clinical trials.
#astrazeneca#bristol-myers-squibb#clinical-trials#drug-discovery#foundry#oncology#pathos-ai

More in Healthcare

Healthcare32 min read

Development of an automated method for audiometric data extraction and analysis using voting optical character recognition

Nature
Healthcare3 min read

Microsoft Says Its New AI Is Better at Diagnosing Patients Than Real Doctors

Futurism
Healthcare2 min read

UK government sets out $800 million for AI security funding

ET AI (The Economic Times)